OptimizeRx Recognized as a Finalist in Questex’s Fierce Pharma Marketing Awards 2021
OptimizeRx was selected as a finalist for its COVID-19 Consumer Health Communications Text Message Campaign. The campaign leveraged OptimizeRx’s text-based patient engagement technology, which is traditionally used for specific therapy support programs, to provide the general public with timely COVID-19 information from a reliable source. The free, interactive text-message alert program delivered COVID-19 updates sourced from the
Fierce Pharma Marketing’s expert panel of judges reviewed all submissions to determine which companies produced thought-provoking, innovative and compelling campaigns across a wide range of media. A full list of judges can be found at https://www.fiercemarketingforum.com/2021%20judges.
The winners will be announced at the Fierce Pharma Marketing Awards Dinner on
“It’s been a challenging year for pharma, but it’s also been a creative and innovative one. Pharma marketers and their agencies quickly embraced pandemic-forced changes—moving to digital communications and figuring out how to shoot TV commercials safely, for instance—and continued to produce creative and compelling campaigns all year. We look forward to seeing everybody in
“SMS campaigns are just one of our access solutions that doctors, and life sciences organizations can utilize to facilitate patient engagement outside of the electronic health record in a familiar and convenient manner. It was a no-brainer for our team to leverage the capabilities of the
Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
Tel (248) 651-6568 (x807)
Media Relations Contact
Tel (754) 245-7070
Investor Relations Contact
Vice President, Fierce Life Sciences Events
Source: OptimizeRx Corporation